Literature DB >> 17312128

CD40-CD40 ligand interaction between dendritic cells and CD8+ T cells is needed to stimulate maximal T cell responses in the absence of CD4+ T cell help.

Maria Genevive H Hernandez1, Lianjun Shen, Kenneth L Rock.   

Abstract

Stimulation of CD40 on APCs through CD40L expressed on helper CD4+ T cells activates and "licenses" the APCs to prime CD8+ T cell responses. Although other stimuli, such as TLR agonists, can also activate APCs, it is unclear to what extent they can replace the signals provided by CD40-CD40L interactions. In this study, we used an adoptive transfer system to re-examine the role of CD40 in the priming of naive CD8+ T cells. We find an approximately 50% reduction in expansion and cytokine production in TCR-transgenic T cells in the absence of CD40 on all APCs, and on dendritic cells in particular. Moreover, CD40-deficient and CD40L-deficient mice fail to develop endogenous CTL responses after immunization. Surprisingly, the role for CD40 and CD40L are observed even in the absence of CD4+ T cells; in this situation, the CD8+ T cell itself provides CD40L. Furthermore, we show that although TLR stimulation improves T cell responses, it cannot fully substitute for CD40. Altogether, these results reveal a direct and unique role for CD40L on CD8+ T cells interacting with CD40 on APCs that affects the magnitude and quality of CD8+ T cell responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17312128     DOI: 10.4049/jimmunol.178.5.2844

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Mechanisms by which chronic ethanol feeding limits the ability of dendritic cells to stimulate T-cell proliferation.

Authors:  Ji Fan; Michelle R Edsen-Moore; Lucas E Turner; Robert T Cook; Kevin L Legge; Thomas J Waldschmidt; Annette J Schlueter
Journal:  Alcohol Clin Exp Res       Date:  2010-10-06       Impact factor: 3.455

2.  Memory CD8+ T cells protect dendritic cells from CTL killing.

Authors:  Payal B Watchmaker; Julie A Urban; Erik Berk; Yutaro Nakamura; Robbie B Mailliard; Simon C Watkins; S Marieke van Ham; Pawel Kalinski
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

3.  CD40L expression permits CD8+ T cells to execute immunologic helper functions.

Authors:  Marco Frentsch; Regina Stark; Nadine Matzmohr; Sarah Meier; Sibel Durlanik; Axel R Schulz; Ulrik Stervbo; Karsten Jürchott; Friedemann Gebhardt; Guido Heine; Morgan A Reuter; Michael R Betts; Dirk Busch; Andreas Thiel
Journal:  Blood       Date:  2013-05-29       Impact factor: 22.113

4.  Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway.

Authors:  Fabienne Haspot; Thomas Fehr; Carrie Gibbons; Guiling Zhao; Timothy Hogan; Tasuku Honjo; Gordon J Freeman; Megan Sykes
Journal:  Blood       Date:  2008-06-24       Impact factor: 22.113

5.  CD29 identifies IFN-γ-producing human CD8+ T cells with an increased cytotoxic potential.

Authors:  Benoît P Nicolet; Aurélie Guislain; Floris P J van Alphen; Raquel Gomez-Eerland; Ton N M Schumacher; Maartje van den Biggelaar; Monika C Wolkers
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-11       Impact factor: 11.205

6.  Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase.

Authors:  Devin B Lowe; Michael H Shearer; Cynthia A Jumper; Robert K Bright; Ronald C Kennedy
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

Review 7.  Advances in cholangiocyte immunobiology.

Authors:  Gaurav Syal; Michel Fausther; Jonathan A Dranoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-06       Impact factor: 4.052

8.  CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals.

Authors:  Matthew W Auten; Weitao Huang; Guixiang Dai; Alistair J Ramsay
Journal:  Vaccine       Date:  2012-02-18       Impact factor: 3.641

Review 9.  The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance.

Authors:  Renee B Chang; Gregory L Beatty
Journal:  J Leukoc Biol       Date:  2020-04-09       Impact factor: 4.962

Review 10.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.